Warp Secures $60 Million in Latest Series B Funding Round

Warp secured $60 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Warp Raises $60 million in Funding

Exclusive: Warp raises $60m to go up against ADP, Rippling. With Warp, the idea is companies "don't even have to understand that there's all these tax jurisdictions that they have to go talk to." Warp tracks the patchwork, flags changes in regulation, and suggests updates to paperwork.

Investors Behind the Funding

The round was backed by the prior year. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Warp operates in Healthcare & Life Sciences. Warp's financing adds to recent private-market activity.

Strategic Use of Funds

Go up against ADP, Rippling.

Looking Ahead

There's over 10,000 tax jurisdictions in the U.S. alone,

Source reference: original announcement/article.